Mcl-1 downregulation leads to the heightened sensitivity exhibited by BCR-ABL positive ALL to induction of energy and ER-stress

Leukemia Research
Guy J LeclercJulio C Barredo

Abstract

BCR-ABL positive (+) acute lymphoblastic leukemia (ALL) accounts for ∼30% of cases of ALL. We recently demonstrated that 2-deoxy-d-glucose (2-DG), a dual energy (glycolysis inhibition) and ER-stress (N-linked-glycosylation inhibition) inducer, leads to cell death in ALL via ER-stress/UPR-mediated apoptosis. Among ALL subtypes, BCR-ABL+ ALL cells exhibited the highest sensitivity to 2-DG suggesting BCR-ABL expression may be linked to this increased vulnerability. To confirm the role of BCR-ABL, we constructed a NALM6/BCR-ABL stable cell line and found significant increase in 2-DG-induced apoptosis compared to control. We found that Mcl-1 was downregulated by agents inducing ER-stress and Mcl-1 levels correlated with ALL sensitivity. In addition, we showed that Mcl-1 expression is positively regulated by the MEK/ERK pathway, dependent on BCR-ABL, and further downregulated by combining ER-stressors with TKIs. We determined that energy/ER stressors led to translational repression of Mcl-1 via the AMPK/mTOR and UPR/PERK/eIF2α pathways. Taken together, our data indicate that BCR-ABL+ ALL exhibits heightened sensitivity to induction of energy and ER-stress through inhibition of the MEK/ERK pathway, and translational repression of Mcl-...Continue Reading

References

Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·T SatoH G Wang
Dec 12, 2003·Nature·Joseph T OpfermanStanley J Korsmeyer
Apr 9, 2004·The New England Journal of Medicine·Ching-Hon PuiJames R Downing
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sven GottschalkNatalie J Serkova
Nov 19, 2004·Current Opinion in Hematology·Parinda A Mehta, Stella M Davies
Feb 19, 2005·Science·Joseph T OpfermanStanley J Korsmeyer
Mar 23, 2005·Cancer Research·Michael G Kharas, David A Fruman
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Jun 16, 2006·The New England Journal of Medicine·Moshe TalpazCharles L Sawyers
Jul 25, 2006·Nature Medicine·Risto KerkeläThomas Force
Jul 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·John R MillsJerry Pelletier
May 13, 2009·Molecular and Cellular Biology·Caroline MorelRoger J Davis
Sep 8, 2010·Biochimica Et Biophysica Acta·Emily F Mason, Jeffrey C Rathmell
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Apr 16, 2011·Leukemia·L S SteelmanJ A McCubrey
Sep 14, 2011·Cancer Research·Silvia Ramírez-PeinadoCristina Muñoz-Pinedo
Jun 14, 2012·Molecular Cancer Research : MCR·Joanna DeSalvoJulio C Barredo
Feb 5, 2013·Nature Immunology·Victor PeperzakDavid M Tarlinton
May 24, 2013·Cancer Chemotherapy and Pharmacology·Huaping LiuTheodore J Lampidis
Sep 11, 2013·Molecular Cancer Therapeutics·Fardokht AbulwerdiZaneta Nikolovska-Coleska
Feb 25, 2014·Apoptosis : an International Journal on Programmed Cell Death·Jian-Guo SunFei-Yan Liu
May 14, 2014·Proceedings of the National Academy of Sciences of the United States of America·Behzad Kharabi MasoulehMarkus Müschen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.